Author:
Kotani Shozo,Azuma Ichiro,Takada Haruhiko,Tsujimoto Masachika,Yamamura Yuichi
Reference210 articles.
1. Ellouz, F., A. Adam, R. Ciorbaru, and E. Lederer. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59: 1317–1325.
2. Kotani, S., Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba, S. Kusumoto, Y. Tarumi, and K. Ikenaka. 1975. Immunoadjuvant activities of synthetic N-acetylmuramyl-peptides oramino acids. Biken J. 18: 105–111.
3. Azuma, I., K. Sugimura, T. Taniyama, M. Yamawaki, Y. Yamamura, S. Kusumoto, S. Okada, and T. Shiba. 1976. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic Nacetylmuramyl-dipeptide and the related compounds. Infect. Immun. 14: 18–27.
4. Tanaka, A., R. Saito, K. Sugimura, I. Morisaki, S. Kotani, S. Kusumoto, and T. Shiba. 1977. Adjuvant activity of synthetic N-acetylmuramyl peptides in rats. Infect. Immun. 15: 131–136.
5. Souvannavong, V., A. Adam, and E. Lederer. 1978. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl D-isoglutamine: comparison with Freund complete adjuvant. Infect. Immun. 19: 966–971.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献